| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
APcK110 manufacturers
- APcK110
-
- $1980.00
-
2026-07-27
- CAS:1001083-74-4
- Purity:
- Supply Ability: 10g
|
| | APcK110 Basic information |
| Product Name: | APcK110 | | Synonyms: | 6-(3,5-Dimethoxyphenyl)-3-(4-fluorophenyl)-1H-pyrazolo[3,4-b]pyridine;APcK110;1H-Pyrazolo[3,4-b]pyridine, 6-(3,5-dimethoxyphenyl)-3-(4-fluorophenyl)- | | CAS: | 1001083-74-4 | | MF: | C20H16FN3O2 | | MW: | 349.36 | | EINECS: | | | Product Categories: | | | Mol File: | 1001083-74-4.mol |  |
| | APcK110 Chemical Properties |
| | APcK110 Usage And Synthesis |
| Uses | APcK 110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. | | in vivo | APcK110 (500 nM; i.p.; every other day for 60 days) shows anti-AML activity in mice[2]. | Animal Model: | Eight-weeks-old female NODSCID mice, OCI/AML3 xenograft mouse model[2] | | Dosage: | 500 nM | | Administration: | Intraperitoneal injection, every other day for 60 days | | Result: | Survival of compound-treated mice was significantly longer compared with mice injected with PBS. |
|
| | APcK110 Preparation Products And Raw materials |
|